The role of microglia in sepsis-associated encephalopathy: a narrative review

Le Zhang1, Mingxing Tang1, Raffaele Falsaperla2

  • 1Department of Pediatric Critical Care Medicine, Anhui Provincial Children's Hospital, Hefei, China.

Translational Pediatrics
|October 27, 2025
PubMed
Abstract

Insights

Sepsis-associated encephalopathy (SAE) involves harmful neuroinflammation driven by microglia imbalance. Targeting neuronal/glial dysfunction, circadian disruption, and the gut-brain axis offers new therapeutic avenues for SAE.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Sepsis-associated encephalopathy (SAE) is a severe brain dysfunction characterized by neuroinflammation and blood-brain barrier (BBB) breakdown.
  • Microglial phenotypic polarization and NLRP3 inflammasome activation are central to SAE pathogenesis, creating a cycle of inflammation and neuronal damage.

Purpose of the Study:

  • To review the mechanisms of neuronal/glial dysfunction, circadian disruption, and gut-brain axis dysregulation in SAE.
  • To emphasize the interactions between these factors and microglial polarization in neuroinflammation.

Main Methods:

  • Systematic literature search in PubMed (1985-2025).
  • Keywords included "microglia", "sepsis-associated encephalopathy", "blood-brain barrier", "microglia polarization", "NLRP3 inflammasome", and "inflammation".

Main Results:

  • SAE involves complex interactions between microglial polarization, neuroinflammation, neuronal/glial dysfunction, circadian disruption, and gut-brain axis imbalance.
  • While targeting microglia shows promise, complete suppression is not advised due to their homeostatic roles.

Conclusions:

  • Future SAE therapies should balance anti-inflammatory effects with preserving microglia's reparative functions.
  • Targeting underexplored domains like circadian rhythms and the gut-brain axis is crucial for improved neuroprotection and clinical outcomes.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
45
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
27
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
30
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
71